Teva Pharmaceutical Industries Ltd. (TEVA) is poised to receive conditional clearance from the European Union for its almost $7 billion takeover of U.S. specialty drugmaker Cephalon Inc. (CEPH), Reuters reported Monday citing a person with direct knowledge of the matter.

The EU executive, which is scheduled to decide by Oct. 13 whether to clear the acquisition, wasn't immediately available for comment, Reuters said.

Full story at http://www.reuters.com/article/2011/10/10/us-cephalon-teva-eu-idUSTRE7993OH20111010

-Dow Jones Newswires; 212-416-2900

Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos Cephalon.
Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos Cephalon.